Loading clinical trials...
Loading clinical trials...
National, Multicenter, Open-Label and Prospective Study Assessment of Efficacy and Safety in Stage 1 and 2 Essential Hypertension With Olmesartan Medoxomil Based Treatment Algorithm From Monotherapy to Association With Hydrochlorothiazide and Amlodipine Besylate
Conditions
Interventions
olmesartan medoxomil + hydrochlorothiazide, if necessary + amlodipine, if necessary
Start Date
August 1, 2006
Primary Completion Date
June 1, 2007
Completion Date
August 1, 2007
Last Updated
June 3, 2009
NCT06823947
NCT06604897
NCT07448506
NCT07433790
NCT07421414
NCT07421401
Lead Sponsor
Daiichi Sankyo
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions